Patent details

EP1438023 Title: Process for preparing crystalline particles of fluticasone, beclomethasone, salmeterol and salbutamol

Basic Information

Publication number:
EP1438023
PCT Application Number:
PCT/GB/2002/004820
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027701077
PCT Publication Number:
WO/2003/035035
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Process for preparing crystalline particles of fluticasone, beclomethasone, salmeterol and salbutamol
French Title of Invention:
Procédé pour la préparation des particules cristallines de fluticasone, beclomethasone, salmeterol et salbutamol
German Title of Invention:
Prozess zur Herstellung kristalliner Partikel von Fluticason, Beclomethason, Salmeterol und Salbutamol
SPC Number:

Dates

Filing date:
23/10/2002
Grant date:
01/03/2006
EP Publication Date:
01/03/2006
PCT Publication Date:
01/05/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/07/2004
EP B1 Publication Date:
01/03/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/10/2006
Expiration date:
23/10/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/10/2002
 
 

Name:
GLAXO GROUP LIMITED
Address:
Glaxo Wellcome House Berkeley Avenue, Greenford, Middlesex UB6 ONN, United Kingdom (GB)

Inventor

Name:
MCLOUGHLIN Martin, John
Address:
United Kingdom (GB)

Priority

Priority Number:
0125604
Priority Date:
25/10/2001
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 9/14;
Filing date Document type Number of pages